These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19339623)

  • 1. Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.
    Carey AN; Lyons AM; Shay CF; Dunton O; McLaughlin JP
    J Neurosci; 2009 Apr; 29(13):4293-300. PubMed ID: 19339623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.
    McLaughlin JP; Land BB; Li S; Pintar JE; Chavkin C
    Neuropsychopharmacology; 2006 Apr; 31(4):787-94. PubMed ID: 16123754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
    Schindler AG; Li S; Chavkin C
    Neuropsychopharmacology; 2010 Aug; 35(9):1932-42. PubMed ID: 20445500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration.
    Sperling RE; Gomes SM; Sypek EI; Carey AN; McLaughlin JP
    Psychopharmacology (Berl); 2010 Jun; 210(2):199-209. PubMed ID: 20401606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system.
    McLaughlin JP; Li S; Valdez J; Chavkin TA; Chavkin C
    Neuropsychopharmacology; 2006 Jun; 31(6):1241-8. PubMed ID: 16123746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.
    McLaughlin JP; Marton-Popovici M; Chavkin C
    J Neurosci; 2003 Jul; 23(13):5674-83. PubMed ID: 12843270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
    Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
    J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system.
    Redila VA; Chavkin C
    Psychopharmacology (Berl); 2008 Sep; 200(1):59-70. PubMed ID: 18575850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice.
    Shin EJ; Jang CG; Bing G; Park DH; Oh CH; Koo KH; Oh KW; Yamada K; Nabeshima T; Kim HC
    Drug Alcohol Depend; 2009 Sep; 104(1-2):175-84. PubMed ID: 19559544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.
    Gillett K; Harshberger E; Valdez GR
    Alcohol; 2013 Aug; 47(5):359-65. PubMed ID: 23731692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
    Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
    J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
    Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate.
    Wiley MD; Poveromo LB; Antapasis J; Herrera CM; Bolaños Guzmán CA
    Neuropsychopharmacology; 2009 Apr; 34(5):1339-50. PubMed ID: 18923399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.
    Walker BM; Kissler JL
    Neuropsychopharmacology; 2013 Oct; 38(11):2278-85. PubMed ID: 23689673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.
    Eans SO; Ganno ML; Reilley KJ; Patkar KA; Senadheera SN; Aldrich JV; McLaughlin JP
    Br J Pharmacol; 2013 May; 169(2):426-36. PubMed ID: 23425081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
    Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
    J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.